The report provides a detailed analysis essential for establishing a dinoprost tromethamine production plant. It encompasses all critical aspects necessary for dinoprost tromethamine production, including the cost of dinoprost tromethamine production, dinoprost tromethamine plant cost, dinoprost tromethamine production costs, and the overall dinoprost tromethamine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a dinoprost tromethamine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dinoprost tromethamine is a synthetic prostaglandin that finds major applications in veterinary practice. It is primarily utilised for the induction of labour or abortion to synchronise estrus in breeding programs in livestock, particularly in cattle and horses. It is also used as a medication to treat conditions such as pyometra or other uterine issues by promoting uterine contractions and expulsion of contents. It finds its main application in the management of certain pregnancy-related procedures, such as inducing labour or helping in the termination of pregnancy in animals. It is primarily used for the induction of labour, as an abortifacient for second-trimester pregnancy termination, and for causing luteolysis in veterinary medicine. It is also used in diagnostic procedures to assist in reproductive management in livestock. In dairy farming, it helps improve herd fertility by allowing better control over breeding schedules. Moreover, it is also used in clinical research focused on reproductive health and hormone-related therapies.
The demand for dinoprost tromethamine is driven by its application as a veterinary prostaglandin to control reproductive events and manage certain reproductive disorders in animals, which supports its market growth. Its application as a drug for inducing labour or abortion in livestock when pregnancies are undesirable or unsafe significantly boosts its demand in veterinary medicine and animal healthcare sectors. Its usage as a veterinary medicine to treat uterine infections and to manage or synchronise estrus cycles for planned breeding also contributes to its demand in the animal healthcare industry. Its demand in the veterinary sector to treat retained placenta and other postpartum issues also supports its market growth.
The rising focus on improving herd fertility rates, increasing demand for high-quality animal protein, and the expansion of organised livestock farming further contribute to its market expansion. In addition, government initiatives supporting animal health and better farm productivity also stimulate product demand. Procurement trends for industrial dinoprost tromethamine are influenced by factors such as the cost and availability of active ingredients, strict veterinary drug regulations, product quality standards, and cold chain requirements. Moreover, advancements in formulation technology, reliable supplier networks, and compliance with animal safety guidelines significantly affect global sourcing and distribution practices.
Raw Material for Dinoprost Tromethamine Production
According to the dinoprost tromethamine production plant project report, the major raw materials for dinoprost tromethamine production include tris(hydroxymethyl)aminomethane and prostaglandin F2α (PGF2α) (the active prostaglandin component).
Production Process of Dinoprost Tromethamine
The extensive dinoprost tromethamine production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of dinoprost tromethamine begins with dissolving tris(hydroxymethyl)aminomethane in water and adding it to a hot acetonitrile solution of PGF2α under vigorous stirring. Then, the mixture is cooled to room temperature, allowing the salt of PGF2α to gradually crystallise out. Crystallisation is induced by controlled nucleation, and the suspension is maintained until complete precipitation. The resulting crystalline product is collected by filtration under an inert atmosphere, washed with acetonitrile, and dried under controlled heating to obtain dinoprost tromethamine as the final product.
Dinoprost Tromethamine is the tromethamine (THAM) salt of the naturally occurring prostaglandin F2α. It appears as a white, hygroscopic powder that is sparingly soluble in water at approximately 1 mg/mL and more readily soluble in ethanol at about 50 mg/mL. The molecular formula of the compound is C24H45NO8, and its molar mass is 475.62 g/mol. The compound has a melting point of 100–101 degrees Celsius and should be stored at -20 degrees Celsius to maintain stability. Its aqueous solutions remain stable for 30 days when kept at 2–8 degrees Celsius and for several months when frozen. It is marketed under brand names such as Prostin F2 Alpha, Lutalyse, and Dinolytic. It is classified as harmful if swallowed and is known to pose serious reproductive hazards, as it may damage both fertility and the unborn child. It is recommended to wear protective gloves, eye shields, and a respirator while handling the compound. Repeated freeze–thaw cycles of its aqueous solutions should be avoided, and single-use aliquots are recommended for proper storage.